Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03137355 · ClinicalTrials.gov registry record
The International Registry for Leigh Syndrome
A clinical trial of Leigh Syndrome and Leigh Disease, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT03137355 is a study of Leigh Syndrome and Leigh Disease that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03137355, a study of Leigh Syndrome and Leigh Disease, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop a database containing clinical and laboratory information for patients with Leigh syndrome. The goal is to provide a greater understanding of Leigh syndrome allowing further characterization of this disease.
Conditions Studied
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2015-06-17 |
| Est. Completion | 2030-06-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03137355
The ClinicalTrials.gov registry entry for NCT03137355 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Leigh Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT03137355 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03137355 about?
NCT03137355 is a clinical study titled "The International Registry for Leigh Syndrome". The purpose of this study is to develop a database containing clinical and laboratory information for patients with Leigh syndrome. The goal is to provide a greater understanding of Leigh syndrome allowing further characterization of this disease.
What is the current status of trial NCT03137355?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2015-06-17. Estimated completion is 2030-06-17.
What conditions does trial NCT03137355 study?
This clinical trial studies the following conditions: Leigh Syndrome, Leigh Disease, Leigh's Necrotizing Encephalopathy, Subacute Necrotizing Encephalomyopathy, Subacute Necrotizing Encephalomyelopathy.
Who is sponsoring clinical trial NCT03137355?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03137355 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Leigh Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.